IgA autoantibodies targeting 2-glycoprotein I are associated with mucosal and vascular immune responses and may contribute to disease heterogeneity in antiphospholipid syndrome. Signosis has developed a mouse Anti-2-GP1 IgA ELISA kit to enable comprehensive isotype-specific autoimmune profiling in murine models.